Zydus Receives Final Approval From The USFDA For Diclofenac Sodium And Misoprostol Delayed Release Tablets
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States (IQVIA MAT Mar. 2023).